0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Adverse Drug Effects
 101-120 of 211 Articles
Original Investigation |  FREE
Qian Xiao, PhD; Rachel A. Murphy, PhD; Denise K. Houston, PhD; et al.
JAMA Intern Med. 2013;173(8):639-646. doi:10.1001/jamainternmed.2013.3283.
Includes: Supplemental Content

Invited Commentary | 
Susanna C. Larsson, PhD
JAMA Intern Med. 2013;173(8):647-648. doi:10.1001/jamainternmed.2013.3769.

Viewpoint | 
Staffan Svensson, MD, PhD; David B. Menkes, MD, PhD; Joel Lexchin, MSc, MD
JAMA Intern Med. 2013;173(8):611-612. doi:10.1001/jamainternmed.2013.3037.
Includes: Supplemental Content

Editor's Correspondence | 
Roy C. Ziegelstein, MD, MACP
JAMA Intern Med. 2013;173(8):713-714. doi:10.1001/jamainternmed.2013.3785.

Editor's Correspondence | 
Joseph V. Rodricks, PhD; Michael H. Lumpkin, PhD
JAMA Intern Med. 2013;173(7):594-595. doi:10.1001/jamainternmed.2013.2533.

Editor's Correspondence | 
Pieter A. Cohen, MD
JAMA Intern Med. 2013;173(7):594-595. doi:10.1001/jamainternmed.2013.3776.

Editor's Correspondence | 
J. Simon Bell, PhD
JAMA Intern Med. 2013;173(7):596-597. doi:10.1001/jamainternmed.2013.3280.

Invited Commentary | 
Belinda Gier, PhD; Peter C. Butler, MD
JAMA Intern Med. 2013;173(7):539-541. doi:10.1001/jamainternmed.2013.3374.

Original Investigation |  FREE
Gregory S. Cooper, MD; Tzuyung D. Kou, PhD; Douglas K. Rex, MD
JAMA Intern Med. 2013;173(7):551-556. doi:10.1001/jamainternmed.2013.2908.

Invited Commentary | 
Karen J. Wernli, PhD; John M. Inadomi, MD
JAMA Intern Med. 2013;173(7):556-558. doi:10.1001/jamainternmed.2013.4071.

Original Investigation |  FREE
Sonal Singh, MD, MPH; Hsien-Yen Chang, PhD; Thomas M. Richards, MS; et al.
JAMA Intern Med. 2013;173(7):534-539. doi:10.1001/jamainternmed.2013.2720.
Includes: Supplemental Content

Original Investigation |  FREE
Marcello Maggio, MD, PhD; Andrea Corsonello, MD; Gian Paolo Ceda, MD; et al.
JAMA Intern Med. 2013;173(7):518-523. doi:10.1001/jamainternmed.2013.2851.
Includes: CME

Original Investigation |  FREE
Jason D. Wright, MD; Alfred I. Neugut, MD, PhD; Cande V. Ananth, PhD; et al.
JAMA Intern Med. 2013;173(7):559-568. doi:10.1001/jamainternmed.2013.2921.

Review Article |  FREE
Timothy J. Wilt, MD, MPH; Roderick MacDonald, MS; Jeannine Ouellette; et al.
JAMA Intern Med. 2013;173(7):496-505. doi:10.1001/jamainternmed.2013.3733.
Includes: Supplemental Content

Original Investigation |  FREE
Omid Sadr-Azodi, MD, PhD; Fredrik Mattsson, BSc; Tomas Sjöberg Bexlius, MD, PhD; et al.
JAMA Intern Med. 2013;173(6):444-449. doi:10.1001/jamainternmed.2013.2737.

Original Investigation |  FREE
Elissa R. Weitzman, ScD, MSc; Skyler Kelemen, BA; Maryanne Quinn, MD, MPH; et al.
JAMA Intern Med. 2013;173(5):345-351. doi:10.1001/jamainternmed.2013.2512.

Research Letters |  FREE
Alan J. Forster, MD, MSc; Claudine Auger, PhD; for the ISTOP ADE Investigators
JAMA Intern Med. 2013;173(5):382-384. doi:10.1001/jamainternmed.2013.2002.

Invited Commentary | 
Michael A. Steinman, MD
JAMA Intern Med. 2013;173(5):384-385. doi:10.1001/jamainternmed.2013.2965.

Original Investigation |  FREE
Gerald Liew, PhD; Paul Mitchell, PhD; Tien Yin Wong, PhD; et al.
JAMA Intern Med. 2013;173(4):258-264. doi:10.1001/jamainternmed.2013.1583.

Invited Commentary | 
Sanjay Kaul, MD; George A. Diamond, MD
JAMA Intern Med. 2013;173(4):264-266. doi:10.1001/jamainternmed.2013.2530.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Ophthalmology
Brief Report  | 
Association of Rivaroxaban Anticoagulation and Spontaneous Vitreous Hemorrhage
Judy H. Jun, BS; John C. Hwang, MD, MBA
JAMA Oncology
Brief Report  | 
Nephrotoxicity of the BRAF Inhibitors Vemurafenib and Dabrafenib
Kenar D. Jhaveri, MD; Vipulbhai Sakhiya, MBBS; Steven Fishbane, MD
JAMA Ophthalmology
Original Investigation  | 
Incidence, Risk Factors, and Timing of Elevated Intraocular Pressure After Intravitreal Triamcinolone Acetonide Injection for Macular Edema Secondary to Retinal Vein Occlusion:  SCORE Study Report 15
Ahmad A. Aref, MD; Ingrid U. Scott, MD, MPH; Neal L. Oden, PhD; et al.
JAMA Oncology
Invited Commentary  | 
JAK/STAT Pathway Inhibitors and Neurologic Toxicity:  Above All Else Do No Harm?
Bart L. Scott, MD; Pamela S. Becker, MD, PhD